BlackMars Capital logo

BlackMars Capital

Europe, Sachsen-Anhalt, Germany, Hessen

Description

BlackMars Capital is a German investment firm that provides capital to fast-growing technology companies.

Investor Profile

BlackMars Capital has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series C (33%)
  • Series Unknown (33%)
  • Seed (33%)

Country Focus

  • Germany (67%)
  • United States (33%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Manufacturing
  • Robotics
  • Biotechnology
  • Health Care
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BlackMars Capital frequently co-invest with?

AC
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
2bX
Europe, Berlin, Germany, Berlin
Co-Investments: 2
CV
North America, Massachusetts, United States, Boston
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
AM
North America, New Jersey, United States, Morristown
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does BlackMars Capital often collaborate with?

GB
Europe, Berlin, Germany, Berlin
Shared Deals: 1
VP
Europe, Berlin, Germany, Berlin
Shared Deals: 1
LC
Europe, Berlin, Germany, Berlin
Shared Deals: 1

What are some of recent deals done by BlackMars Capital?

Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
Circus Group

Hamburg, Hamburg, Germany

Disrupting food-service operations with the use of AI robotics and proprietary software solutions.

Artificial Intelligence (AI)ManufacturingRobotics
Series UnknownJul 17, 2023
Amount Raised: $6,181,387
Circus Group

Hamburg, Hamburg, Germany

Disrupting food-service operations with the use of AI robotics and proprietary software solutions.

Artificial Intelligence (AI)ManufacturingRobotics
SeedNov 24, 2022
Amount Raised: $11,448,626